$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Nov 3, 2025)
$6.74B
Market Cap
-
P/E Ratio
-5.06
EPS
$139.13
52 Week High
$75.56
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Axsome Therapeutics, Inc. is a biopharmaceutical company based in New York City, dedicated to developing innovative therapies for central nervous system (CNS) disorders. The company is focused on addressing significant unmet medical needs within this therapeutic area, boasting a robust pipeline of candidates targeting conditions such as depression, migraine, and chronic pain. With a strong commitment to enhancing patient outcomes and a solid scientific foundation, Axsome is strategically positioned to deliver transformative solutions in CNS medicine, making it a compelling prospect for institutional investors looking to capitalize on advancements in mental health treatment.
 MSPR
 VHAI
 EZGO
 KVUE
 NVDA
 BYND
 ASST
 RAY
 PFE
 CIFR
 BITF
 DNN
 PLUG
 T
 TSLA
 SOFI
 F
 IREN
 GRAB
 PLTR
 CRBU
 EPWK
 DVLT
 MSAI
 WULF
 INTC
 NOK
 RGTI
 RIG
 NIO
 AAL
 ADAP
 AREC
 FUBO
 RXRX
 IOVA
 THAR
 QBTS
 RNTX
 QS
 LUMN
 JOBY
 WBD
 SNAP
 VZ
 CAN
 MARA
 VALE
 KMB
 AMD
 BTBT
 SOUN
 UUUU
 CDE
 PBR
 HIMS
 TERN
 RIOT
 CMG
 AMCR
 META
 NVTS
 CURR
 CLSK
 BAC
 TLRY
 QURE
 LAZR
 CORZ
 LAES
 GOOGL
 UBER
 MSPR
 VHAI
 EZGO
 KVUE
 NVDA
 BYND
 ASST
 RAY
 PFE
 CIFR
 BITF
 DNN
 PLUG
 T
 TSLA
 SOFI
 F
 IREN
 GRAB
 PLTR
 CRBU
 EPWK
 DVLT
 MSAI
 WULF
 INTC
 NOK
 RGTI
 RIG
 NIO
 AAL
 ADAP
 AREC
 FUBO
 RXRX
 IOVA
 THAR
 QBTS
 RNTX
 QS
 LUMN
 JOBY
 WBD
 SNAP
 VZ
 CAN
 MARA
 VALE
 KMB
 AMD
 BTBT
 SOUN
 UUUU
 CDE
 PBR
 HIMS
 TERN
 RIOT
 CMG
 AMCR
 META
 NVTS
 CURR
 CLSK
 BAC
 TLRY
 QURE
 LAZR
 CORZ
 LAES
 GOOGL
 UBER